Next-ChemX Corporation

Nuclein is an innovative company based in Austin, Texas, specializing in advanced diagnostic solutions such as the DASH Rapid PCR System and DASH SARS-CoV-2 Flu A B Test. Their focus is on providing efficient and reliable testing options to meet the evolving needs of healthcare providers and patients. Committed to enhancing public health, Nuclein utilizes cutting-edge technology to deliver rapid diagnostic results. The company is dedicated to transparency and user privacy, ensuring that customer information is handled with care in accordance with their privacy policy. Generated from the website

Paradromics, Inc., based in Austin, Texas, is at the forefront of brain-computer interface (BCI) technology, focusing on high-data rate and high-reliability applications aimed at transforming brain health. Founded by CEO Matt Angle, the company blends expertise in neurotechnology, data science, and medical devices to create advanced BCI platforms that promise groundbreaking applications. The team includes notable figures such as COO James Burrows and CSO Vikash Gilja, contributing their extensive experience to drive the development of innovative neurotech solutions. In 2023, Paradromics received FDA Breakthrough Device Designation for its speech decoding technology, marking a significant milestone in its commitment to advancing healthcare through neurotechnology. Generated from the website

Mu Therapeutics Inc, based in Austin, TX, specializes in the development of targeted radiotherapeutics aimed at treating rare and challenging cancers in both adults and children. Their innovative approach utilizes Rhenium radioisotopes encapsulated in nanoliposomes and biodegradable microspheres to deliver precise radiation therapy while minimizing damage to healthy tissues. The company's lead products include REYOBIQ, a radiolabeled nanoliposome therapy for brain and CNS cancers, and 188RNL-BAM, a next-generation radioembolization therapy designed for various solid organ cancers. By leveraging cutting-edge drug formulations and treatment technologies, Mu Therapeutics is dedicated to improving patient outcomes and extending quality of life through innovative cancer therapies. Generated from the website